Meet with us at VIVE 2024!

Add Your Heading Text Here

RPM Dashboard
Article

Why Start a Remote Patient Monitoring Program?

6 min read

Accessing a patient’s key health metrics remotely was something few healthcare providers could envision just a few decades ago. Today, this technology is readily available, with medical-grade health devices collecting and securely transmitting patient health data directly to physicians. Remote patient monitoring (RPM) programs offer many benefits for both patients and healthcare providers. Let’s explore how this technology can provide higher-quality care for patients while improving the profitability and sustainability of medical practices. We’ll also share a quick checklist you can use to decide if starting a remote patient monitoring program is the right choice for your patients and practice.

How a Remote Patient Monitoring Program Benefits Patients

Connected health devices can be used to monitor important health stats like blood pressure, heart rate, weight, sleep patterns, and more. Many patients get a lot out of participating in a remote patient monitoring program, including those who are managing chronic conditions (i.e. diabetes, hypertension), going through post-op recovery, or who live in a rural community or lack access to reliable transportation. Here are six specific ways RPM programs benefit patients.

Higher levels of patient engagement

One of the most important factors in improving patient health outcomes is engagement. Patients who are actively engaged in their own care are more likely to proactively engage with their healthcare providers and take charge of adjusting lifestyle factors that may be impacting their overall health. Remote patient monitoring technology puts actionable health information within easy reach, allowing patients and their care providers to view both current health metrics as well as trends over time.

Greater patient ownership of health outcomes

Remote patient monitoring connects patients with their own health metrics, allowing them to play a greater role in monitoring their health. Health data is displayed on an intuitive app that allows patients to track progress over time. Easy access to health data empowers patients to see how they can improve their health by adjusting lifestyle factors within their control.

Improved access to care

Patients may face many barriers when it comes to accessing medical care. Long commutes, work and childcare obligations, and a lack of reliable transportation are just a few of the roadblocks to overcome. And in rural communities, the closest provider may be hundreds of miles away. Remote patient monitoring technologies can be used as part of a holistic health program to offer more convenient care when and where patients need it.

Additional data to better inform treatment and early detection of health conditions

In-person visits provide just a snapshot in time of key health metrics like weight, heart rate, and blood pressure, and because these measurements are taken infrequently and in an abnormal environment, these measurements may paint an inaccurate picture of a patient’s health. Remote patient monitoring devices, in contrast, can collect readings much more frequently and can be set to alert providers when numbers indicate the presence of health issues that require urgent attention.

Reduced patient cost for monitoring chronic health conditions

Actively monitoring chronic health conditions can place a significant logistical and financial burden on patients who must make frequent visits to their healthcare providers, since these visits require time off of work as well as transportation-related expenses. Participating in a remote patient monitoring program enables physicians to collect key health data remotely, potentially reducing the number of required in-person visits.

Improved quality of care

Remote patient monitoring can result in significant improvements in the quality of care that patients receive. As noted above, it provides a valuable source of additional health data for providers, leading to more informed care. More frequent readings can enable earlier detection of critical health issues that require timely intervention, and can help physicians catch deteriorating conditions before they become problematic. They also provide a more holistic view of a patient’s health. Additionally, when patients have immediate access to their own health data they can be more motivated to make important lifestyle changes and take a more active role in their health outcomes.

How a Remote Patient Monitoring Program Benefits Primary Care Practices

Launching a remote patient monitoring program can unlock a host of benefits for primary medical practices. For providers seeking to improve the quality of patient care, boost revenue, and remain competitive, offering remote patient monitoring can help accomplish these goals.

Improved quality of care and patient oversight

Remote patient monitoring technologies measure health metrics with much greater frequency than in-office visits and allow healthcare professionals the ability to spot sudden changes that may require time-sensitive intervention. For example, with an RPM program, physicians can track weight as part of fluid management in patients with CHF.

Longitudinal care

Tracking patient health trends over time provides physicians and other healthcare professionals with valuable trend data that can be used to better manage patient care. For example, providers can more easily see how a chronic illness has progressed over time with a quick glance at a data chart.

Opportunities to expand the patient base

Now that remote patient monitoring technologies have matured, patients are starting to recognize the value and convenience of enrolling in one of these programs. The proliferation of wearable technology, such as the ScanWatch, has contributed. Establishing a robust remote patient monitoring program in your practice can attract new patients eager for the advantages it can provide.

Increased patient satisfaction

Remote patient monitoring programs result in happier patients. That’s no surprise. This technology enables patients to avoid unnecessary office visits, spend more time at work or home, and access their own health data with a few clicks of a mobile app. Research backs up this assertion. A 2021 study found that 91% of post-discharge COVID-19 patients monitored remotely using a pulse oximeter would recommend it to others.

Improved profitability for the practice

Remote patient monitoring can result in more efficient workflows, boosting the productivity of office staff and healthcare providers and enabling more patients access to care. RPM programs include several billable services reimbursable by Medicare and private insurers.

Checklist to Identify if an RPM Program Is Right for Your Practice

Although remote patient monitoring programs have a lot to offer, some patients and medical practices will benefit from them more than others. Here are a few important questions to ask when deciding if launching a remote patient monitoring program is the right move for your practice.

  • Would your current patients benefit from this technology?
  • Do a significant number of your patients have chronic health conditions such as hypertension, heart failure, COPD, or diabetes?
  • Do a significant number of your patients have health conditions requiring short-term monitoring such as those recovering from an acute condition like severe illness, injury, or a recent hospitalization?
  • Do some of your patients struggle to keep frequent in-person visits due to living in remote locations, lack of transportation, or schedule conflicts due to work or primary caregiver obligations?
  • Is your practice eager to expand billable services and take on additional patients?
  • Do you have adequate buy-in from office staff and physicians?

Withings Health Solutions Makes Starting an RPM Program Simple

Starting a remote patient monitoring program from scratch can feel like a daunting task. That’s why partnering with the right remote patient monitoring provider is so important. Every healthcare provider has been through the pain of technical integrations that take far more time and money than planned. Withings Health Solutions understands the challenges, and we know that everyone has different needs and processes. This is why we offer carefully designed data connection solutions for devices and RPM. During program setup, Withings Health Solutions handles all the onboarding and manages support, freeing your team to focus on patients, not managing tech.

With over a decade of industry experience, Withings Health Solutions offers medical-grade devices that feature intuitive designs that encourage high user adoption and retention rates, including a sleep tracking mat, remote blood pressure cuff, and smart scale. Our patient-facing Health Mate mobile app puts health data within easy reach, displaying it in a way that’s personalized and easy to understand. Our physician data dashboard offers intuitive, continuous access to all your patients’ critical health data in near-real time so you can provide better care to your patients. When you’re ready to launch your remote patient monitoring program, we’re ready to help.

Learn more about Withings Health Solutions for remote patient monitoring.

Don’t miss out,  subscribe to get the latest content updates.  

Related Content

WP_Query Object ( [query] => Array ( [post_type] => post [post_status] => publish [orderby] => date [order] => DESC [ignore_sticky_posts] => 1 [post__not_in] => Array ( [0] => 377 ) [cat] => 18 [posts_per_page] => 3 ) [query_vars] => Array ( [post_type] => post [post_status] => publish [orderby] => date [order] => DESC [ignore_sticky_posts] => 1 [post__not_in] => Array ( [0] => 377 ) [cat] => 18 [posts_per_page] => 3 [error] => [m] => [p] => 0 [post_parent] => [subpost] => [subpost_id] => [attachment] => [attachment_id] => 0 [name] => [pagename] => [page_id] => 0 [second] => [minute] => [hour] => [day] => 0 [monthnum] => 0 [year] => 0 [w] => 0 [category_name] => articles [tag] => [tag_id] => [author] => [author_name] => [feed] => [tb] => [paged] => 0 [meta_key] => [meta_value] => [preview] => [s] => [sentence] => [title] => [fields] => [menu_order] => => [category__in] => Array ( ) [category__not_in] => Array ( ) [category__and] => Array ( ) [post__in] => Array ( ) [post_name__in] => Array ( ) [tag__in] => Array ( ) [tag__not_in] => Array ( ) [tag__and] => Array ( ) [tag_slug__in] => Array ( ) [tag_slug__and] => Array ( ) [post_parent__in] => Array ( ) [post_parent__not_in] => Array ( ) [author__in] => Array ( ) [author__not_in] => Array ( ) [search_columns] => Array ( ) [suppress_filters] => [cache_results] => 1 [update_post_term_cache] => 1 [update_menu_item_cache] => [lazy_load_term_meta] => 1 [update_post_meta_cache] => 1 [nopaging] => [comments_per_page] => 50 [no_found_rows] => ) [tax_query] => WP_Tax_Query Object ( [queries] => Array ( [0] => Array ( [taxonomy] => category [terms] => Array ( [0] => 18 ) [field] => term_id [operator] => IN [include_children] => 1 ) ) [relation] => AND [table_aliases:protected] => Array ( [0] => wp_term_relationships ) [queried_terms] => Array ( [category] => Array ( [terms] => Array ( [0] => 18 ) [field] => term_id ) ) [primary_table] => wp_posts [primary_id_column] => ID ) [meta_query] => WP_Meta_Query Object ( [queries] => Array ( ) [relation] => [meta_table] => [meta_id_column] => [primary_table] => [primary_id_column] => [table_aliases:protected] => Array ( ) [clauses:protected] => Array ( ) [has_or_relation:protected] => ) [date_query] => [request] => SELECT SQL_CALC_FOUND_ROWS wp_posts.ID FROM wp_posts LEFT JOIN wp_term_relationships ON (wp_posts.ID = wp_term_relationships.object_id) WHERE 1=1 AND wp_posts.ID NOT IN (377) AND ( wp_term_relationships.term_taxonomy_id IN (18) ) AND wp_posts.post_type = 'post' AND ((wp_posts.post_status = 'publish')) GROUP BY wp_posts.ID ORDER BY wp_posts.post_date DESC LIMIT 0, 3 [posts] => Array ( [0] => WP_Post Object ( [ID] => 1188 [post_author] => 8 [post_date] => 2024-04-16 08:12:38 [post_date_gmt] => 2024-04-16 08:12:38 [post_content] =>

Calls have been growing louder to more effectively address the related problems of diabetes-related foot ulcers (DFUs) and amputations, two of the most serious consequences of diabetes-related peripheral neuropathy (DPN). Health associations like the American Diabetes Association® (ADA), patient advocacy groups, patients, and providers all see the need to improve the detection of DPN, earlier intervention, and more effective treatments to combat an amputation problem that disproportionately impacts communities of color and lower economic status.

 

Unfortunately, there is not a large body of research related to the question of simple compliance with the ADA’s standard of an annual foot exam for people with diabetes. However, a study published in Clinical Nursing Research journal in 2017 indicated only 16% of patient charts reviewed in a specialty clinic met the ADA’s standard for an annual foot exam. Clinicians regularly report seeing patients who present with serious DFUs who have never had a proper foot examination.

 

With the goal of promoting patient education on diabetes-related foot health, earlier detection of neuropathy, and regular diabetes-related foot exams, Withings has partnered with the ADA’s Project Power to put smart scales in the homes of approximately 2,305 participants in 849 cities with particularly high-risk and vulnerable communities. Project Power’s goal is to reduce diabetes risk factors and improve diabetes health literacy, self-care behaviors, and glycemic management. The program is conducted with a combination of in-person and remote sessions that focus on topics such as nutrition, exercise, emotional health, heart health, glucose monitoring, and foot health.

 

Sherry Hill, program director for Project Power, commented, “We are excited to be working with Withings to bring the Project Power participant experience to the next level. By bringing smart scale technology into our participants’ homes, we hope to provide personalized solutions to achieve healthier living goals to reduce the risk for type 2 diabetes and help prevent or delay its complications.”

 

For Withings, Project Power is one of the many examples of how its sophisticated health technology is being used to better connect patients and their health coaches with appropriate care from a clinician. By flagging potential issues earlier and setting up regular monitoring, patient health outcomes can be improved. Through early interventions, lifestyle changes have a better chance of slowing complications.


Learn more about Project Power.

Interested in partnering with us?

Contact Us [post_title] => The ADA and Withings Join Forces to Reduce Diabetes Risk and Complications [post_excerpt] => Peer-reviewed studies have shown that only a fraction of people with diabetes comply with the American Diabetes Association (ADA) standard of annual foot exams. The ADA is now using Withings smart scales in its signature Project Power program to promote regular foot exams and better foot health for people at high-risk for diabetes [post_status] => publish [comment_status] => closed [ping_status] => closed [post_password] => [post_name] => ada-and-withings-diabetic-foot-health [to_ping] => [pinged] => [post_modified] => 2024-04-16 08:12:39 [post_modified_gmt] => 2024-04-16 08:12:39 [post_content_filtered] => [post_parent] => 0 [guid] => https://withingshealthsolutions.com/?p=1188 [menu_order] => 0 [post_type] => post [post_mime_type] => [comment_count] => 0 [filter] => raw ) [1] => WP_Post Object ( [ID] => 1183 [post_author] => 1 [post_date] => 2024-04-16 08:11:42 [post_date_gmt] => 2024-04-16 08:11:42 [post_content] =>

In an interview with Harvard Medical School’s Harvard Health, Dr. Khosro Farhad, a neuropathy expert at Harvard-affiliated Massachusetts General Hospital, noted that small-fiber neuropathy is generally underdiagnosed because routine neurological exams and tests cannot accurately discriminate between large-fiber and small-fiber neuropathy. 

 

In a literature review of diabetic peripheral neuropathy diagnostic and screening technologies in the Journal of Diabetes Science and Technology, Kelley Newlin Lew et al pointed out that the body of research backs up the assertion that distal symmetrical peripheral neuropathy  - including both small- and large-fiber neuropathy - is underdiagnosed in primary care (1).

 

The article points out: 

Small- and large-nerve fiber DSPN (distal symmetrical peripheral neuropathy) may present exclusively or together while each subtype may increase risk for foot ulceration due to reduced sensory function, and thereby heightened risk for lower extremity amputations. According to the ADA, the clinical history and physical examination often are sufficient for diagnosis of DSPN. Yet, up to 50% of individuals with DSPN may be asymptomatic.

 

Small-fiber DSPN typically precedes large-fiber neuropathy. Small-fiber DSPN impairs functional integrity of the small thinly myelinated Aδ and unmyelinated C fibers. These small, peripheral nerve fibers prominently convey pain to the central nervous system. In DSPN, they may stimulate profound pain. Small-fiber DSPN may also adversely affect local autonomic (eg, decreased sweating, dry skin, impaired vasomotion) and thermoreceptor (cold, warm sensations) functions.

 

Often, pain and other symptoms and signs first manifest in the feet and progress proximally to the lower extremities and, in some cases, to the hands with a stocking and glove pattern. However, some with small-fiber DSPN may not experience pain. A proportion of patients with small-fiber neuropathy may present with little evidence of the disease, which may delay DSPN diagnosis.

 

 

The primary care practitioner’s toolbox for diagnosing diabetic peripheral neuropathy has been very limited to date, with tools such as temperature and pin-prick sensation, 128-Hz tuning fork, and 10-g monofilament that are neither quantifiable nor reproducible and are prone to human error. Further, since the ADA Standards of Care only call for annual foot exams for people with a diagnosis of diabetes, a large number of patients with pre-diabetes accompanied by the onset of small fiber neuropathy, miss the chance for an early diagnosis (2,3).

 

Withings is focused intently on this deficit in detection technologies in primary care and other frontline environments. As Newlin Lew points out in the Journal of Diabetes Science and Technology article, the Sudoscan® Electrochemical Skin Conductance (ESC) technology being used in our Body Pro 2 device, and that has been used in clinical settings for nearly a decade, could play an important role in improving detection and monitoring:   

 

When considered with respect to past and more recent research, Sudoscan has substantial evidence revealing it may potentially identify early DSPN (although this is not its main use) and monitor DSPN progression over time. Sudoscan also has adequate reproducibility and repeatability. Sudoscan is approved by the FDA and may be reimbursed through proper billing. Sudoscan is thus a POCD [point of care device] worthy of clinical adoption to detect and monitor DSPN in clinical settings.

 

  1. Newlin Lew K, Arnold T, Cantelmo C, Jacque F, Posada-Quintero H, Luthra P, Chon KH. Diabetes Distal Peripheral Neuropathy: Subtypes and Diagnostic and Screening Technologies. Journal of Diabetes Science and Technology. 2022 Mar;16(2):295-320. doi: 10.1177/19322968211035375. Epub 2022 Jan 7. PMID: 34994241; PMCID: PMC8861801. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8861801/
  2. Williams SM, Eleftheriadou A, Alam U, Cuthbertson DJ, Wilding JPH. Cardiac Autonomic Neuropathy in Obesity, the Metabolic Syndrome and Prediabetes: A Narrative Review. Diabetes Ther. 2019 Dec;10(6):1995-2021. doi: 10.1007/s13300-019-00693-0. Epub 2019 Sep 24. Erratum in: Diabetes Ther. 2019 Oct 4;: PMID: 31552598; PMCID: PMC6848658. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6848658/
  3.  Burgess J, Frank B, Marshall A, Khalil RS, Ponirakis G, Petropoulos IN, Cuthbertson DJ, Malik RA, Alam U. Early Detection of Diabetic Peripheral Neuropathy: A Focus on Small Nerve Fibres. Diagnostics (Basel). 2021 Jan 24;11(2):165. doi: 10.3390/diagnostics11020165. PMID: 33498918; PMCID: PMC7911433. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7911433/

Interested in partnering with us?

Contact Us [post_title] => Small Fiber Neuropathy - The Under-Diagnosed Peripheral Neuropathy [post_excerpt] => In an interview with Harvard Medical School’s Harvard Health, Dr. Khosro Farhad, a neuropathy expert at Harvard-affiliated Massachusetts General Hospital, noted that small-fiber neuropathy is generally underdiagnosed because routine neurological exams and tests cannot accurately discriminate between large-fiber and small-fiber neuropathy. [post_status] => publish [comment_status] => closed [ping_status] => closed [post_password] => [post_name] => small-fiber-neuropathy-the-under-diagnosed-peripheral-neuropathy [to_ping] => [pinged] => [post_modified] => 2024-04-16 08:17:26 [post_modified_gmt] => 2024-04-16 08:17:26 [post_content_filtered] => [post_parent] => 0 [guid] => https://withingshealthsolutions.com/?p=1183 [menu_order] => 0 [post_type] => post [post_mime_type] => [comment_count] => 0 [filter] => raw ) [2] => WP_Post Object ( [ID] => 1184 [post_author] => 1 [post_date] => 2024-04-16 08:09:33 [post_date_gmt] => 2024-04-16 08:09:33 [post_content] =>

Electrochemical Skin Conductance (ESC) is a physiological parameter that measures the reactivity of sweat glands and small nerve fibers in the skin to electrical stimuli. Elevated blood sugar levels can harm blood vessels, inhibiting their ability to supply oxygen and essential nutrients to these small nerves, leading to their deterioration. This effect is amplified because the nerve fibers that supply sweat glands are long, thin and unmyelinated, they are easily damaged. When the sweat glands and small nerve fibers lose functionality, it is a sign of starting peripheral neuropathy.


Diabetic peripheral neuropathy (DPN) affects the majority of patients with diabetes, but it is difficult to diagnose in its early stages because up to half of those affected are asymptomatic (no pain and good feet sensation). These undetected signs and lack of care can lead to Diabetic Foot Ulcer (DFU) and in the worst case to amputation(1). Though late stage DPN cannot be reversed, early detection can help to slow the progression through exercise, HbA1c control, addressing certain vitamin deficiencies, and other lifestyle changes. According to the American Academy of Family Physicians, early detection and treatment of DPN and resulting foot ulcers has the potential to prevent up to 85% of amputations (2,3).


Many studies have demonstrated the link between sudomotor function and the risk for DPN paving the way for the use of the Sudoscan within DPN characterization (4,5,6,7). ESC has now a 15+ year track record of R&D and a body of peer-reviewed research in more than 200 scientific publications. Because of this vast array of clinical evidence,Withings decided to integrate the ESC measurement into its scales leading to the Body Pro 2 device. To measure ESC, patients simply step on the Body Pro 2 scale (8). Electrodes in the scale emit a small painless current to the feet, and the device measures the resulting chloride conductance in the sweat glands. Within 60 seconds, patients and their providers receive their ESC score (and other biomarkers). Low conductance, and thus a low ESC score, indicates sudomotor dysfunction with a known threshold to stratify patients. 


With a persistent DFU and amputation problem impacting millions of people with diabetes, it is clear that current clinical methods and patient compliance are insufficient to markedly reduce incidences. Even for patients who have their annual foot exam, the conventional monofilament test results in a misdiagnosis nearly half the time (9). Skin biopsies are conclusive, but invasive, painful, and especially problematic for patients who have a high risk of infection and whose wounds heal slowly. By contrast, our ESC technology provides a rapid, operator-independent, and reproducible method that can replace monofilament and balance the drawbacks of invasive biopsy.


While preventing DFUs is a complex problem requiring multi-faceted solutions, we are already working with leading providers in the U.S., Europe and Asia to enable easier and more reliable diagnosis and monitoring of DPN using the ESC technology in Body Pro 2. Importantly, we believe that the quantifiable, reproducible, rapid and non-invasive methodology has far more potential for scaling in proportion to the size of the DFU problem, and can better serve the requirements of a highly diverse patient population. 

  1.  Armstrong, D. G., Tan, T.-W., Boulton, A. J. M. & Bus, S. A. Diabetic Foot Ulcers: A Review. JAMA 330, 62–75 (2023).  https://jamanetwork.com/journals/jama/article-abstract/2806655
  2.  Hunt, D. Diabetes: Foot Ulcers and Amputations. Am. Fam. Physician 80, 789–790 (2009).  https://www.aafp.org/pubs/afp/issues/2009/1015/p789.html
  3.  Esquenazi, A., Kwasniewski, M. Lower Limb Amputations: Epidemiology and Assessment. PM&R KnowledgeNow (2017). https://now.aapmr.org/lower-limb-amputations-epidemiology-and-assessment/
  4.  Galiero, R. et al. Peripheral Neuropathy in Diabetes Mellitus: Pathogenetic Mechanisms and Diagnostic Options. Int. J. Mol. Sci. 24, 3554 (2023). https://doi.org/10.3390/ijms24043554
  5.  Casellini, C. M., Parson, H. K., Richardson, M. S., Nevoret, M. L. & Vinik, A. I. Sudoscan, a noninvasive tool for detecting diabetic small fiber neuropathy and autonomic dysfunction. Diabetes Technol. Ther. 15, 948–953 (2013). https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3817891/
  6.  Vinik, A. I., Nevoret, M.-L. & Casellini, C. The New Age of Sudomotor Function Testing: A Sensitive and Specific Biomarker for Diagnosis, Estimation of Severity, Monitoring Progression, and Regression in Response to Intervention. Front. Endocrinol. 6, 94 (2015). https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4463960/
  7. Novak, P. Electrochemical skin conductance: a systematic review. Clin. Auton. Res. Off. J. Clin. Auton. Res. Soc. 29, 17–29 (2019). https://doi.org/10.1007/s10286-017-0467-x
  8.  Riveline, J.-P. et al. Validation of the Body Scan®, a new device to detect small fiber neuropathy by assessment of the sudomotor function: agreement with the Sudoscan®. Front. Neurol. 14, (2023). https://doi.org/10.3389/fneur.2023.1256984
  9.  Dube, S. et al. Effectiveness of Semmes Weinstein 10 gm monofilament in diabetic peripheral neuropathy taking nerve conduction and autonomic function study as reference tests. J. Fam. Med. Prim. Care 11, 6204–6208 (2022). https://doi.org/10.4103/jfmpc.jfmpc_195_22

Interested in partnering with us?

Contact Us [post_title] => Understanding our ESC Technology for Detecting and Monitoring DPN [post_excerpt] => Electrochemical Skin Conductance (ESC) is a physiological parameter that measures the reactivity of sweat glands and small nerve fibers in the skin to electrical stimuli. Elevated blood sugar levels can harm blood vessels, inhibiting their ability to supply oxygen and essential nutrients to these small nerves, leading to their deterioration. This effect is amplified because the nerve fibers that supply sweat glands are long, thin and unmyelinated, they are easily damaged. When the sweat glands and small nerve fibers lose functionality, it is a sign of starting peripheral neuropathy. [post_status] => publish [comment_status] => closed [ping_status] => closed [post_password] => [post_name] => understanding-our-esc-technology-for-detecting-and-monitoring-dpn [to_ping] => [pinged] => [post_modified] => 2024-04-16 08:15:45 [post_modified_gmt] => 2024-04-16 08:15:45 [post_content_filtered] => [post_parent] => 0 [guid] => https://withingshealthsolutions.com/?p=1184 [menu_order] => 0 [post_type] => post [post_mime_type] => [comment_count] => 0 [filter] => raw ) ) [post_count] => 3 [current_post] => -1 [before_loop] => 1 [in_the_loop] => [post] => WP_Post Object ( [ID] => 1188 [post_author] => 8 [post_date] => 2024-04-16 08:12:38 [post_date_gmt] => 2024-04-16 08:12:38 [post_content] =>

Calls have been growing louder to more effectively address the related problems of diabetes-related foot ulcers (DFUs) and amputations, two of the most serious consequences of diabetes-related peripheral neuropathy (DPN). Health associations like the American Diabetes Association® (ADA), patient advocacy groups, patients, and providers all see the need to improve the detection of DPN, earlier intervention, and more effective treatments to combat an amputation problem that disproportionately impacts communities of color and lower economic status.

 

Unfortunately, there is not a large body of research related to the question of simple compliance with the ADA’s standard of an annual foot exam for people with diabetes. However, a study published in Clinical Nursing Research journal in 2017 indicated only 16% of patient charts reviewed in a specialty clinic met the ADA’s standard for an annual foot exam. Clinicians regularly report seeing patients who present with serious DFUs who have never had a proper foot examination.

 

With the goal of promoting patient education on diabetes-related foot health, earlier detection of neuropathy, and regular diabetes-related foot exams, Withings has partnered with the ADA’s Project Power to put smart scales in the homes of approximately 2,305 participants in 849 cities with particularly high-risk and vulnerable communities. Project Power’s goal is to reduce diabetes risk factors and improve diabetes health literacy, self-care behaviors, and glycemic management. The program is conducted with a combination of in-person and remote sessions that focus on topics such as nutrition, exercise, emotional health, heart health, glucose monitoring, and foot health.

 

Sherry Hill, program director for Project Power, commented, “We are excited to be working with Withings to bring the Project Power participant experience to the next level. By bringing smart scale technology into our participants’ homes, we hope to provide personalized solutions to achieve healthier living goals to reduce the risk for type 2 diabetes and help prevent or delay its complications.”

 

For Withings, Project Power is one of the many examples of how its sophisticated health technology is being used to better connect patients and their health coaches with appropriate care from a clinician. By flagging potential issues earlier and setting up regular monitoring, patient health outcomes can be improved. Through early interventions, lifestyle changes have a better chance of slowing complications.


Learn more about Project Power.

Interested in partnering with us?

Contact Us [post_title] => The ADA and Withings Join Forces to Reduce Diabetes Risk and Complications [post_excerpt] => Peer-reviewed studies have shown that only a fraction of people with diabetes comply with the American Diabetes Association (ADA) standard of annual foot exams. The ADA is now using Withings smart scales in its signature Project Power program to promote regular foot exams and better foot health for people at high-risk for diabetes [post_status] => publish [comment_status] => closed [ping_status] => closed [post_password] => [post_name] => ada-and-withings-diabetic-foot-health [to_ping] => [pinged] => [post_modified] => 2024-04-16 08:12:39 [post_modified_gmt] => 2024-04-16 08:12:39 [post_content_filtered] => [post_parent] => 0 [guid] => https://withingshealthsolutions.com/?p=1188 [menu_order] => 0 [post_type] => post [post_mime_type] => [comment_count] => 0 [filter] => raw ) [comment_count] => 0 [current_comment] => -1 [found_posts] => 22 [max_num_pages] => 8 [max_num_comment_pages] => 0 [is_single] => [is_preview] => [is_page] => [is_archive] => 1 [is_date] => [is_year] => [is_month] => [is_day] => [is_time] => [is_author] => [is_category] => 1 [is_tag] => [is_tax] => [is_search] => [is_feed] => [is_comment_feed] => [is_trackback] => [is_home] => [is_privacy_policy] => [is_404] => [is_embed] => [is_paged] => [is_admin] => [is_attachment] => [is_singular] => [is_robots] => [is_favicon] => [is_posts_page] => [is_post_type_archive] => [query_vars_hash:WP_Query:private] => 105fc667f4d08f564af148470782ed1f [query_vars_changed:WP_Query:private] => [thumbnails_cached] => [allow_query_attachment_by_filename:protected] => [stopwords:WP_Query:private] => [compat_fields:WP_Query:private] => Array ( [0] => query_vars_hash [1] => query_vars_changed ) [compat_methods:WP_Query:private] => Array ( [0] => init_query_flags [1] => parse_tax_query ) )
Article

The ADA and Withings Join Forces to Reduce Diabetes Risk and Complications

Read More
Article

Small Fiber Neuropathy – The Under-Diagnosed Peripheral Neuropathy

Read More
Article

Understanding our ESC Technology for Detecting and Monitoring DPN

Read More

Interested in partnering with Withings Health Solutions?

Contact Us

References

About withings health solutions
For developers
For researchers
© 2023 Withings All rights reserved. Terms & Conditions Privacy Policy Cookie Policy
Linkedin